Latest publications

Diagnostic accuracy of Ara h 2 for detecting peanut allergy in children. Kansen HM, Van Erp FC, Meijer Y, Gorissen DMW, Stadermann M, Van Velzen MF et al. Clin Exp Allergy 2021 Jul 20

Poor understanding of allergen labelling by allergic and non-allergic consumers. Holleman BC, Van Os-Medendorp H, Van den Bergh H, Van Dijk LM, Linders YFM, Blom WM et al. Clin Exp Allergy 2021 Jul 20

Systemic and local evidence for complement involvement in chronic spontaneous urticaria. Alizadeh Aghdam M, Van den Elzen M, Van Os-Medendorp H, Van Dijk MR, Knol EF, Knulst AC et al. Clin Transl Allergy 2021 Jul; 11(5):e12011

Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters. Bakker DS, De Graaf M, Nierkens S, Delemarre EM, Knol E, Van Wijk F et al. J Allergy Clin Immunol 2021 Jul 06

Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry. Oosterhaven JAF, Spekhorst LS, Zhang J, Voorberg AN, Romeijn GLE, Boesjes CM et al. J Dermatolog Treat 2021 Jun 21:1-4

Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials. Griffiths C, De Bruin-Weller M, Deleuran M, Fargnoli MC, Staumont-Sallé D, Hong CH et al. Dermatol Ther (Heidelb) 2021 Aug; 11(4):1357-1372

Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis. Simpson EL, De Bruin-Weller M, Bansal A, Chen Z, Nelson L, Whalley D et al. Dermatol Ther (Heidelb) 2021 Aug; 11(4):1415-1422

Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data. El Sharouni MA, Ahmed T, Witkamp AJ, Sigurdsson V, Van Gils CH, Nieweg OE et al. Br J Surg 2021 May 27; 108(5):550-553

Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use. Deleuran M, Marcoux D, Bruin-Weller MS, Irvine AD, Baselga E, Ahn K et al. Acta Derm Venereol 2021 Jul 15; 101(7):adv00504

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Reich K, Teixeira HD, De Bruin-Weller M, Bieber T, Soong W, Kabashima K et al. Lancet 2021 06 05; 397(10290):2169-2181

Comparison of Two Strategies to Generate Antigen-Specific Human Monoclonal Antibodies: Which Method to Choose for Which Purpose? Ehlers AM, Den Hartog Jager CF, Kardol-Hoefnagel T, Katsburg MMD, Knulst AC, Otten HG et al. Front Immunol 2021; 12:660037

Distinction between peanut allergy and tolerance by characterization of B​ cell receptor repertoires. Ehlers AM, Den Hartog Jager CF, Knulst AC, Otten HG et al. Allergy 2021 May 10

Cuperus E, Sigurdsson V, Van den Akker PC, Bolling MC, Van Gijn ME, Pasmans SGMA et al. J Dtsch Dermatol Ges 2021 Apr; 19(4):611-614

Nomenclature and clinical phenotypes of atopic dermatitis. Girolomoni G, De Bruin-Weller M, Aoki V, Kabashima K, Deleuran M, Puig L et al. Ther Adv Chronic Dis 2021; 12:20406223211002979

High discordance rate in assessing sentinel node positivity in cutaneous melanoma: Expert review may reduce unjustified adjuvant treatment. El Sharouni MA, Laeijendecker AE, Suijkerbuijk KP, Witkamp AJ, Sigurdsson V, Van Diest PJ et al. Eur J Cancer 2021 May; 149:105-113